COVID-19 AND THE CV SERVICE LINE –Part 5€¦ · • 501(c)(3) with
COVID-19 and Beyond/media/Non-Clinical/Files-PDFs-Excel-MS-Word-etc/2020/05/27/...May 27, 2020 ·...
13
John S. Rumsfeld, MD PhD FACC Chief Science Officer & Chief Innovation Officer, American College of Cardiology Professor of Medicine, University of Colorado School of Medicine COVID-19 and Beyond ACC and Clinical Research
Transcript of COVID-19 and Beyond/media/Non-Clinical/Files-PDFs-Excel-MS-Word-etc/2020/05/27/...May 27, 2020 ·...
John S. Rumsfeld, MD PhD FACCChief Science Officer & Chief Innovation Officer, American College of Cardiology
Professor of Medicine, University of Colorado School of Medicine
COVID-19 and BeyondACC and Clinical Research
2020
March April May
RAASMyocardial damageHQC / Long QTPPEProning teams
2020
March
April May
ThrombosisKawasaki-like syndromeCV Care in COVID eraDelays in / avoidance of CV careCOVID-19 treatments / RCTsRe-opening
2020
March April May
>150 trials launched
multinational registry671 hospitals; 6 continents96,032 COVID-19 patients
risk of mortalityrisk of ventricular arrythmias
Has COVID-19 changed the way you think about clinical evidence?
What are the largest challenges and opportunities for clinical research?
What are the key questions we should should be addressing?
How can ACC lead?
